Tirzepatide, the active ingredient in Lilly's new drug, is already approved under the trade name Mounjaro, a diabetes drug, but Zepbound will list for a lower pre-insurance price than Novo Nordisk's weight loss drug, Wegovy.

New survey from FinanceBuzz.com sheds light on the state-of-mind of remote or hybrid workers.

Nearly half (47%) of all adults look forward to each day, compared to 43% last year.

Incentives for alternative payment models, which Congress created in 2015 to help providers move into new payment models that encourage high quality, cost-effective care, will expire Dec. 31 unless lawmakers extend it.

The preference for contactless payments has doubled within two years, with as many as 33% of patients preferring to use digital wallets, PayPal or Venmo.

The lawsuit, which alleges that the pharmacy benefit manager colluded with Prime Therapeutics to charge higher fees, comes weeks after an independent pharmacy association launched an investigation into PBM fees.

New report indicates more than half of American workers are experiencing at least moderate burnout, often magnified by workplace stress.

79% indicated their employer has a responsibility to make sure employees are mentally healthy and emotionally well.